Immucor

Sirona Genomics was spun out of the Stanford Genome Technology Center (SGTC) at Stanford University with a focus on developing next generation sequencing typing applications specifically for the HLA System. Based in Mountain View, CA, the company was founded by Ron Davis, Ph.D., Director of the SGTC and Professor of Biochemistry and Genetics at Stanford University; Mark Davis, Ph.D., Director of Stanford Institute for Immunity, Transplantation and Infection, and Professor of Microbiology and Immunology at Stanford University; Michael Mindrinos, Ph.D., former Associate Director of the SGTC; Marcelo Fernández-Viña, Ph.D., Professor for the Department of Pathology at Stanford University Medical School, co-Director of the Histocompatibility, Immunogenetics and Disease Profiling Laboratory at Stanford University; Sujatha Krishnakumar, former Life Science Research Associate at SGTC; and Chunlin Wang, former Senior Research Scientist at SGTC.

Durham, NC-based Sentilus was founded in 2012 and is developing an inkjet-printed antibody microarray-based technology called Femtoarrays for use in in vitro diagnostics, including transfusion diagnostics.

Organ-i is a biotechnology diagnostic company focused on transforming the diagnosis of renal diseases, particularly in transplant recipients. The company has developed non-invasive tests that utilize a proprietary, clinically validated gene-based biomarker to assist healthcare professionals in diagnosing kidney rejection. These innovative tests significantly enhance clinicians' abilities to monitor the health of transplanted kidneys and provide essential treatment information for patients. Organ-i holds an exclusive license for this patented technology from Stanford University and is currently initiating commercial operations in Northern California. Additionally, the company has a pipeline of molecular assays aimed at monitoring post-transplant rejection and allograft tolerance.